SPY308.08+2.53 0.83%
DIA257.85+2.58 1.01%
IXIC9,608.38+56.33 0.59%

IGM Biosciences Q1 EPS $(0.580) Misses $(0.550) Estimate

IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(0.580) per share which missed the analyst consensus estimate of $(0.550) by 5.45 percent.

Benzinga · 05/07/2020 20:11

IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(0.580) per share which missed the analyst consensus estimate of $(0.550) by 5.45 percent.